Seamless Therapeutics Receives Funding To Advance Gene Editing Platform
Seamless Therapeutics has received $12.5 million in seed funding to advance a revolutionary gene editing platform based on programmable precision
Read moreSeamless Therapeutics has received $12.5 million in seed funding to advance a revolutionary gene editing platform based on programmable precision
Read moreThe Huc enzyme has the potential to be used in tiny air-powered devices because it has the ability to convert
Read moreLuciferases enzymes, as the name implies, catalyze chemical reactions that emit light; they are responsible for the firefly’s flare. Researchers
Read moreA partnership with biotech company Arzeda will see the companies computer designing new enzymes with superior benefits to help clean
Read more